Full-Time

Clinical Neuropsychologist

Posted on 9/12/2025

Deadline 8/25/26
BrightSpring Health Services

BrightSpring Health Services

10,001+ employees

Home-based and community health services, pharmacy

No salary listed

Austin, TX, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Requirements
  • PhD or PsyD in Psychology or in an accredited training program in Neuropsychology.
  • Maintains professional Psychology license and/or certification as required by the state in which the psychologist practices.
  • Minimum of two years post-doctoral training in Clinical Neuropsychology.
  • Minimum of three years clinical experience in the assessment and management of traumatic brain injury or related neurological conditions is generally required.
  • Knowledge of complex neurologic injury and orthopedic rehabilitation techniques are generally required.
  • Current BLS (Basic Life Support) First Aid and CPR certifications.
  • Demonstrates effective and professional interpersonal, verbal, and written communication skills.
  • Able to work independently and part of a team.
  • Organized and able to function under minimal supervision.
  • Has reliable transportation and able to travel to/from multiple assignments/locations on a daily basis.
Responsibilities
  • Performs periodic formal assessments and evaluations, assessing needs of patients and setting measurable objectives in conjunction with the treatment team. Provides feedback/input to the patient, family and treatment team regarding cognitive/neuropsychological rehabilitation issues, test results and their practical application.
  • Provides counseling/psychotherapy and education to the patient and family regarding the adjustment process and programmatic outcome. If applicable for program, leads groups in accordance with appropriate group dynamics.
  • Designs community reintegration activities to assist the patient with their psychological/cognitive needs during physical activity and assists the patient in understanding their needs and limitations and how to manage them.
  • Provides documentation of treatment progress and status in accordance with the Plan of Treatment and adjusts when necessary to achieve maximum results.
  • Reports progress to the rehabilitation staff, patient/family/support system. Observes/documents and reports changes in the condition of the patient to the Clinical Coordinator/designee, attending physician and other treatment team members as appropriate.
  • Participates in the team process, provides input and effective treatment strategies. Attends case conference and family educational meetings.
  • Develops, teaches and assesses the plan of treatment. Guides and supervises the Rehabilitation Specialist/Certified Nursing Assistant in fulfillment of the plan. Uses appropriate methods and tools in all teaching and training activities, including those associated with discharge from treatment.
  • Adheres to standards of the Company's Code of Business Conduct, policies, HIPAA and Corporate Compliance programs and appropriate professional practice standards and applicable state/federal laws.
  • Performs other duties as assigned.
Desired Qualifications
  • Ability to lift fifty (50) pounds. Moving, lifting, or transferring of patients may involve lifting of up to 100 pounds.
  • Ability to stand for extended periods.
  • Fine motor skills.
  • Visual acuity.
  • Duties require extensive standing and walking.
  • Requires lifting, positioning, pushing, and/or transferring patients.
  • Duties require frequent reaching, stooping, bending, kneeling, and crouching.
BrightSpring Health Services

BrightSpring Health Services

View

BrightSpring Health Services provides home and community-based health care through two main operations: Pharmacy and Provider. In Pharmacy, it offers services for patients with complex and chronic conditions, including specialty, infusion, and community pharmacy solutions. In Provider, it delivers home health, behavioral health, hospice care, and services for intellectual and developmental disabilities. The company uses an integrated care model that connects pharmacy services with in-home care across its network to support patients, families, and managed care organizations. Revenue comes from reimbursed services paid by Medicare, Medicaid, and private insurers. Its goal is to coordinate ongoing, in-home and community-based care across a continuum—from pharmacy support to direct care—ensuring coordinated, patient-centered services for individuals with complex or chronic needs.

Company Size

10,001+

Company Stage

Post IPO Equity

Headquarters

Louisville, Kentucky

Founded

1974

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $3.61B, up 26%, raising full-year guidance to $14.98B.
  • Amedisys and LHC acquisitions add 107 locations, contributing $30M EBITDA in 2026.
  • Sevita sale yields $811M cash for debt reduction and $2B M&A through 2028.

What critics are saying

  • Money Message ransomware stole 2M records including SSNs in March 2023 breach.
  • DOJ fined ResCare in October 2019 for fake Medicaid revaluations from 2009-2014.
  • Pomerantz investigates securities fraud by BrightSpring officers as of 2026.

What makes BrightSpring Health Services unique

  • BrightSpring integrates specialty pharmacy with home health for complex chronic care patients.
  • PharMerica dispenses 40 million prescriptions annually to 4 million patients.
  • Provider services target intellectual disabilities via home-based behavioral health.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Company News

Yahoo Finance
Apr 10th, 2026
BrightSpring Health shares jump 5.2% on 15-20% EBITDA growth targets and AI efficiency plans

BrightSpring Health Services announced the resignation of Robert Barnes as President of ResCare Community Living on 30 March 2026, stating it was not due to any disagreement over operations or policies. The company's shares rose 5.2% following upbeat analyst reports from its investor day. Management unveiled ambitious long-term organic EBITDA growth targets of 15% to 20% annually through 2028, alongside AI-driven efficiency plans for its home and community-based care platform. The narrative projects $16.8 billion in revenue and $361.8 million in earnings by 2028, requiring 10.1% yearly revenue growth. Investors remain focused on whether BrightSpring can balance acquisition-driven expansion and technology investment whilst managing its substantial debt load and regulatory exposure.

Yahoo Finance
Mar 30th, 2026
BrightSpring Health Services stock surges 43% in 6 months, but low ROIC raises concerns

BrightSpring Health Services has seen its stock price surge 43.1% over the past six months to $42.32 per share, driven by strong quarterly results. The healthcare services company, founded in 1974, offers home health care, hospice, neuro-rehabilitation and pharmacy services. BrightSpring's revenue grew at an 18.3% compound annual growth rate over the past five years, outpacing the healthcare sector average. Analysts forecast 15% revenue growth over the next 12 months, though this represents a deceleration from its recent 20.9% annual rate. However, the company's five-year average return on invested capital of 4.9% falls below the typical cost of capital for healthcare firms, suggesting historically mediocre capital efficiency. The stock currently trades at 27.7× forward price-to-earnings ratio.

Yahoo Finance
Mar 25th, 2026
BrightSpring trades at 24.5x forward P/E despite $600M revenue headwinds

BrightSpring Health Services has raised questions about its valuation after trading at 24.5 times forward earnings following strong 2025 performance. The company reported fourth-quarter revenue of $3.55 billion, up 29.3% year-over-year, with adjusted EBITDA rising 40.7% to $184 million. For 2026, management guided revenue between $14.45 billion and $15 billion, representing 11.9% to 16.2% growth, whilst adjusted EBITDA is expected to grow faster at 23% to 28%, indicating margin expansion. However, the company faces approximately $600 million in revenue headwinds from Inflation Reduction Act impacts and brand-to-generic conversions. The valuation hinges on whether BrightSpring can deliver sequential profitability improvements throughout the year despite policy and product-mix pressures affecting headline revenue growth.

Yahoo Finance
Mar 24th, 2026
BrightSpring tops Q4 senior health earnings as Chemed's $639M revenue disappoints

BrightSpring Health Services led senior health stocks in Q4 earnings, reporting revenues of $3.55 billion, up 16.3% year on year and beating analyst expectations by 5%. The company delivered strong full-year EBITDA guidance. In contrast, Chemed posted the weakest performance, with revenues of $639.3 million falling 3% short of expectations. The company missed both revenue and full-year EPS guidance estimates, sending shares down 19.2% to $377.07. The seven senior health, home health and hospice stocks tracked reported slower Q4 results overall, with revenues beating consensus estimates by just 1.1%. Share prices have declined an average of 9.6% since earnings releases. The sector faces headwinds from labour shortages and wage inflation whilst benefiting from an ageing population and growing preference for in-home care.

Yahoo Finance
Mar 19th, 2026
BrightSpring projects sub-2x leverage in 2026, unveils $2B M&A firepower and integrated care strategy

BrightSpring Health Services outlined its growth strategy at an investor day, highlighting a shift towards core home-and-community clinical services. The company's planned community-living divestiture will close soon to boost cash flow and support integrated care initiatives. BrightSpring reported significant deleveraging from approximately 4.5x post-IPO to 2.99x (2.6x pro forma), with leverage expected to fall below 2x in 2026. The company reiterated 2026 guidance of $14.45–$15.0 billion revenue and $760–$790 million adjusted EBITDA, whilst targeting 15–20% organic adjusted EBITDA compound annual growth for 2026–2028. The healthcare services provider has at least $2 billion available for acquisitions through 2028. Its operations include dispensing over 40 million prescriptions annually through PharMerica, serving more than 4 million patients, with recent branch integrations expected to add approximately $30 million of EBITDA.

INACTIVE